Plasma p-tau levels may show variations within and between individuals based on factors unrelated to AD, such as body mass index (BMI), age, or sex, which poses a potential limitation in their utility in AD diagnosis and prognosis (Figure 3). Here, MAPT is linked to Alzheimer disease.